TFRC and renal cell carcinoma: The relative iron-deficient state of metastatic RCC primary tumors and their metastases might translate into increased responsiveness of patients with advanced RCC to iron deprivation therapy, particularly because TfR1 is already overexpressed in metastatic RCC, and further feedback elevation in response to iron depletion may therefore be limited (28).